Eliquis, like Xarelto and Pradaxa, is part of a class of drugs known as New Oral Anticoagulants (NOACs). NOACs have entered the United States market in the past few years and have earned their respective manufacturers billions of dollars in sales in that short period of time. The reason for…
Product Liability Lawyer Blog
Researchers Examine Problems with “Low-T” Diagnosis
Over the past decade, more and more people have started taking testosterone replacement therapy (TRT) drugs to treat the alleged symptoms of having a “low-t” count. Low-T is a term created by the marketing arm of drug companies intended to mean a person has a lower than average testosterone count.…
New Total Hip Replacement Surgery Technique
Each year over 330,000 hip replacement surgeries are performed in the United States. A total hip replacement surgery, known to doctors as arthroplasty, traditionally involves cutting through most of the patient’s muscle tissue, tendons, and bone surrounding the original hip joint. An artificial hip is then anchored to the bone…
New Test Finds Dangers in Antidepressants in Early Development Phase
New drugs can yield billions of dollars for pharmaceutical companies. Because it takes many years to develop a drug, undergo clinical trials, and get it to market, drug companies will do virtually anything to get as much profit as possible for each new drug. This is especially true when considering…
Xarelto Sued Over Clotting Problems
Xarelto is a member of a class of drugs known as New Oral Anticoagulants (NOACs), along with Eliquis, and Pradaxa. These drugs were designed to replace older blood-thinning drugs such as warfarin, which requires frequent monitoring of a patient’s blood to prevent dangerous side effects. The problem with Xarelto and…
What Does the Arrest of NECC Executives Mean For Victims of Meningitis Outbreak?
Our Boston product liability lawyers recently discussed the arrest of NECC owners and employees in connection with the meningitis outbreak that occurred in 2012. The outbreak, which left 64 dead and caused more than 750 people to contract meningitis, was traced to contaminated steroids from the New England Compounding Center.…
Artificial Knee Manufacturer Pleads Guilty to Fraud
According to a recent news article from NJ.com, the president and founder of OtisMed Corp. recently admitted to shipping hundreds of artificial knee products without FDA approval and pleaded guilty to criminal charges. Authorities are reporting defendant pleaded to guilty to three misdemeanor fraud counts related to a shipment of…
Brinkley v. Pliva, Inc.: Defective Generic Drug Lawsuits
Brinkley v. Pliva, Inc., a defective drugs case from the United States Court of Appeals for the Eighth Circuit, involved plaintiff whose doctor prescribed the brand-name drug Reglan to treat her Gastro Esophageal Reflux Disease (GERD). Plaintiff’s pharmacist substituted the generic drug metoclopramide, which was manufactured by defendant. This occurred…
Two Years After NECC Meningitis Outbreak, the Aftermath of The Tragedy Continues
In 2012, a meningitis outbreak was traced to a New England compounding facility. As our Boston product liability lawyers wrote at the time, multiple drugs were linked to the meningitis outbreak. More than two years later, many of the victims and their family members are still trying to get justice…
Framingham Compounding Pharmacy Owners Charged with Murder
According to a recent news article from CBS Boston, the founders of a Framingham compounding pharmacy and 12 other employees have been charged with racketeering and second-degree murder. Court papers indicated the compounding pharmacy was only licensed to manufacture small numbers of specific drugs for individual patients. This is the…